An update on iron homeostasis: Make new friends, but keep the old

Cindy N. Roy

Research output: Contribution to journalArticle

Abstract

A classic Girl Scout song says, "Make new friends/but keep the old/One is silver/and the other gold." This review focuses on the past decade of discovery in the field of iron homeostasis, which has identified "new friends" or key modifiers of the critical systemic iron regulator, hepcidin antimicrobial peptide. The foundation for these discoveries has been the identification of mutated genes in well-characterized cohorts of patients with inherited hemochromatosis from across the globe. Transgenic mouse models of iron overload and iron-restricted anemia have also contributed to understanding molecular pathophysiology in ways that could never be accomplished in human subjects alone. The majority of these newly discovered molecules coordinate signaling through the bone morphogenetic protein pathway of ligands, receptors and coreceptors, intracellular signaling and transcription. The discovery of these proteins and their interactions with "old friends," such as the 1st known hereditary hemochromatosis gene product, HFE and transferrin receptor, has opened the field of iron homeostasis to include regulatory networks involving signal transduction pathways, in particular, the mitogen-activated protein kinase and Smad pathways. These newly discovered partnerships have also made way for opportunities to develop novel therapeutics for the treatment of iron regulatory disorders, including hemochromatosis.

Original languageEnglish (US)
Pages (from-to)413-419
Number of pages7
JournalAmerican Journal of the Medical Sciences
Volume346
Issue number5
DOIs
StatePublished - Nov 2013

Fingerprint

Homeostasis
Iron
Hemochromatosis
Hepcidins
Bone Morphogenetic Proteins
Transferrin Receptors
Iron Overload
Music
Mitogen-Activated Protein Kinases
Silver
Gold
Transgenic Mice
Genes
Anemia
Signal Transduction
Ligands
Peptides
Therapeutics
Proteins

Keywords

  • Bone morphogenetic protein
  • Hepcidin
  • Hereditary hemochromatosis
  • Iron homeostasis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

An update on iron homeostasis : Make new friends, but keep the old. / Roy, Cindy N.

In: American Journal of the Medical Sciences, Vol. 346, No. 5, 11.2013, p. 413-419.

Research output: Contribution to journalArticle

@article{04f896c59d634914892f67dd96fd9166,
title = "An update on iron homeostasis: Make new friends, but keep the old",
abstract = "A classic Girl Scout song says, {"}Make new friends/but keep the old/One is silver/and the other gold.{"} This review focuses on the past decade of discovery in the field of iron homeostasis, which has identified {"}new friends{"} or key modifiers of the critical systemic iron regulator, hepcidin antimicrobial peptide. The foundation for these discoveries has been the identification of mutated genes in well-characterized cohorts of patients with inherited hemochromatosis from across the globe. Transgenic mouse models of iron overload and iron-restricted anemia have also contributed to understanding molecular pathophysiology in ways that could never be accomplished in human subjects alone. The majority of these newly discovered molecules coordinate signaling through the bone morphogenetic protein pathway of ligands, receptors and coreceptors, intracellular signaling and transcription. The discovery of these proteins and their interactions with {"}old friends,{"} such as the 1st known hereditary hemochromatosis gene product, HFE and transferrin receptor, has opened the field of iron homeostasis to include regulatory networks involving signal transduction pathways, in particular, the mitogen-activated protein kinase and Smad pathways. These newly discovered partnerships have also made way for opportunities to develop novel therapeutics for the treatment of iron regulatory disorders, including hemochromatosis.",
keywords = "Bone morphogenetic protein, Hepcidin, Hereditary hemochromatosis, Iron homeostasis",
author = "Roy, {Cindy N.}",
year = "2013",
month = "11",
doi = "10.1097/MAJ.0000000000000190",
language = "English (US)",
volume = "346",
pages = "413--419",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - An update on iron homeostasis

T2 - Make new friends, but keep the old

AU - Roy, Cindy N.

PY - 2013/11

Y1 - 2013/11

N2 - A classic Girl Scout song says, "Make new friends/but keep the old/One is silver/and the other gold." This review focuses on the past decade of discovery in the field of iron homeostasis, which has identified "new friends" or key modifiers of the critical systemic iron regulator, hepcidin antimicrobial peptide. The foundation for these discoveries has been the identification of mutated genes in well-characterized cohorts of patients with inherited hemochromatosis from across the globe. Transgenic mouse models of iron overload and iron-restricted anemia have also contributed to understanding molecular pathophysiology in ways that could never be accomplished in human subjects alone. The majority of these newly discovered molecules coordinate signaling through the bone morphogenetic protein pathway of ligands, receptors and coreceptors, intracellular signaling and transcription. The discovery of these proteins and their interactions with "old friends," such as the 1st known hereditary hemochromatosis gene product, HFE and transferrin receptor, has opened the field of iron homeostasis to include regulatory networks involving signal transduction pathways, in particular, the mitogen-activated protein kinase and Smad pathways. These newly discovered partnerships have also made way for opportunities to develop novel therapeutics for the treatment of iron regulatory disorders, including hemochromatosis.

AB - A classic Girl Scout song says, "Make new friends/but keep the old/One is silver/and the other gold." This review focuses on the past decade of discovery in the field of iron homeostasis, which has identified "new friends" or key modifiers of the critical systemic iron regulator, hepcidin antimicrobial peptide. The foundation for these discoveries has been the identification of mutated genes in well-characterized cohorts of patients with inherited hemochromatosis from across the globe. Transgenic mouse models of iron overload and iron-restricted anemia have also contributed to understanding molecular pathophysiology in ways that could never be accomplished in human subjects alone. The majority of these newly discovered molecules coordinate signaling through the bone morphogenetic protein pathway of ligands, receptors and coreceptors, intracellular signaling and transcription. The discovery of these proteins and their interactions with "old friends," such as the 1st known hereditary hemochromatosis gene product, HFE and transferrin receptor, has opened the field of iron homeostasis to include regulatory networks involving signal transduction pathways, in particular, the mitogen-activated protein kinase and Smad pathways. These newly discovered partnerships have also made way for opportunities to develop novel therapeutics for the treatment of iron regulatory disorders, including hemochromatosis.

KW - Bone morphogenetic protein

KW - Hepcidin

KW - Hereditary hemochromatosis

KW - Iron homeostasis

UR - http://www.scopus.com/inward/record.url?scp=84887252574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887252574&partnerID=8YFLogxK

U2 - 10.1097/MAJ.0000000000000190

DO - 10.1097/MAJ.0000000000000190

M3 - Article

C2 - 24157963

AN - SCOPUS:84887252574

VL - 346

SP - 413

EP - 419

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 5

ER -